Licensed from American College of Cardiology

• LIVE-Yoga: Benefit of Yoga as Adjunctive Therapy to Reduce Recurrent Vasovagal Syncope For patients with recurrent vasovagal syncope (VVS), adding yoga to standard therapy may be more effective than standard therapy alone in reducing symptoms and improving quality of life.
  ACC.org, April 27, 2022
• Standard Baseline Therapy Needed For HF Patients in Trials There is agreement among clinical investigators, regulators, and other key stakeholders that standardized baseline treatment is important for studying new therapies.
  ACC.org, April 20, 2022
• What Are the Determinants of Cardiovascular Disease Risk Equivalents Among Adults with Diabetes Mellitus? For patients with diabetes without prior CVD, there is higher associated relative CVD risk among women, patients of younger age, White race, elevated CRP or triglyceride levels, or decreased kidney function.
  ACC.org, February 23, 2022
• Mavacamten Improves Pathophysiological Markers in HCM A secondary analysis of the EXPLORER- HCM trial showed improvement in LV diastolic function and other markers in patients treated with this drug.
  ACC.org, February 16, 2022